Redesign Science Raises $15M To Advance Computational Structure-Based Drug Discovery
Dec 08, 2021•over 3 years ago
Amount Raised
$15 Million
Description
Redesign Science, a platform technology company combining physics, computer science and biotechnology to advance new small molecule therapeutics, announced the successful completion of Seed-2 and Seed-3 financings, for a total of $15 million. Redesign Science pushes into the next frontier of computational drug discovery - exploring the druggable potential of dynamic biological targets.
Funding Insights
Based on industry dataTech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech